More recently, Qadir et al. found a robust connection between death receptor CD95/FAS, Type I IFN-dependent phosphorylation of STAT1 and stemness in human breast cancer and squamous carcinoma cell lines, which can, in part, explain the correlation between STAT1 activation and therapy resistance observed in these cancer cells [235]. This evidence concerns the gene STAT1 and breast carcinoma.